Arête Therapeutics Inc.


	HOME SITEMAP


				News July 8, 2008 Arête Therapeutics Names James Sabry, M.D., Ph.D., President and Chief Executive Officer January 22, 2008 Arête Therapeutics Adds Jim Bristol as Scientific and Strategic Advisor December 6, 2007 Arête Therapeutics Appoints Donald Santel to Board of Directors November 1, 2007 Arête Therapeutics Initiates Phase 1 Clinical Trial for AR9281 as a First-in-class Antihypertensive Agent May 23, 2007 Arête Therapeutics Raises $35 Million


	HOME \| ABOUT US \| DEVELOPMENT \| DISCOVERY \| NEWS \| INVESTORS \| CAREERS \| CONTACT \| SITEMAP © 2008 Arête Therapeutics Inc. All rights reserved.